Skip to main content

Table 3 Mean (SD) and p-value for between group differences using linear mixed models

From: Addition of MoodGYM to physical treatments for chronic low back pain: A randomized controlled trial

 

Baseline

Post-treatment (max. 8-weeks)

6 months

12 months

Mean differences between groups (0–12 months)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

p value

Outcome

Control group (n = 54)

Intervention group (n = 54)

Control group (n = 54)

Intervention group (n = 52)

Control group (n = 52)

Group 2 Intervention (n = 51)

Control group (n = 49)

Intervention group (n = 49)

Primary

 RMD

9.9 (4.7)

9.9 (4.2)

5.8 (5.1)

5.4 (3.8)

5.0 (4.6)

5.1 (4.0)

5.3 (5.1)

4.2 (3.7)

0.70

 PSEQ

37.8 (13.0)

40.1 (10.0)

44.3 (13.8)

45.2 (12.0)

45.7 (11.5)

45.9 (11.7)

47.6 (12.2)

50.2 (9.4)

0.52

Secondary

 Pain and function

  PNRS

4.9 (2.05)

5.1 (1.8)

2.9 (2.0)

2.8 (2.0)

3.2 (2.2)

3.2 (2.2)

4.0 (2.1)

3.0 (2.1)

0.95

  WAI

5.6 (2.1)

5.7 (2.1)

6.3 (2.3)

6.5 (2.0)

6.4 (2.3)

6.5 (1.9)

6.2 (2.5)

6.8 (2.2)

0.62

 Psychological

  PCS Total

20.9 (12.5)

20.0 (11.3)

14.9 (10.5)

15.5 (11.6)

11.5 (8.8)

13.4 (9.8)

12.8 (10.1)

11.8 (10.0)

0.89

  PCS Rumination

7.6 (4.3)

7.6 (4.2)

5.8 (4.1)

5.6 (4.1)

4.6 (3.7)

5.1 (3.7)

5.1 (4.2)

4.5 (3.7)

0.97

  PCS Magnification

4.2 (3.0)

3.6 (2.8)

2.8 (2.2)

2.9 (2.6)

2.1 (1.8)

2.4 (2.2)

2.6 (2.2)

2.1 (2.5)

0.69

  PCS Helplessness

9.1 (6.0)

8.9 (5.6)

6.4 (4.9)

7.0 (5.7)

4.8 (3.9)

6.0 (4.6)

5.1 (4.4)

5.2 (4.8)

0.61

  DASS21 Total

16.8 (12.6)

15.0 (10.1)

13.3 (11.3)

12.2 (9.5)

11.0 (9.0)

10.8 (7.3)

11.2 (9.4)

9.8 (8.1)

0.49

  DASS21 Depression

5.5 (5.3)

5.3 (4.8)

4.2 (4.5)

4.2 (4.6)

3.0 (3.0)

3.7 (3.8)

3.5 (3.5)

3.2 (3.5)

0.98

  DASS21 Anxiety

3.6 (3.6)

2.8 (2.9)

3.0 (3.3)

2.4 (2.7)

2.6 (3.0)

2.0 (2.1)

2.7 (3.3)

2.1 (2.5)

0.19

  DASS21 Stress

7.7 (4.7)

7.0 (3.9)

6.1 (4.3)

5.6 (3.3)

5.4 (3.8)

5.2 (3.1)

5.0 (3.7)

4.4 (3.2)

0.41

  1. Note: The baseline within-group means were calculated from baseline data. The within-group mean estimates for post-treatment 6 and 12 – months were calculated from linear mixed models